Efficacy and patient satisfaction in the use of subcutaneous immunoglobulin immunotherapy for the treatment of auto-immune neuromuscular diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and patient satisfaction in the use of subcutaneous immunoglobulin immunotherapy for the treatment of auto-immune neuromuscular diseases

Published:2018-09 Issue:9 Volume:17 Page:873-881
ISSN:1568-9972
Container-title:Autoimmunity Reviews
language:en
Short-container-title:Autoimmunity Reviews

Author:

Sala Taylor Pindi,Crave Jean-Charles,Duracinsky Martin,Lepira Bompeka François,Tadmouri Abir,Chassany Olivier,Cherin Patrick

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference67 articles.

1. Autoimmune neuromuscular disorders;Kraker;Curr Neuropharmacol,2011

2. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases;Elovaara;Eur J Neurol,2008

3. International consensus guidance for management of myasthenia gravis: executive summary;Sanders;Neurology,2016

4. Intravenous immunoglobulins and antiphospholipid syndrome: how, when and why? A review of the literature;Tenti;Autoimmun Rev,2016

5. Immunotherapy of myositis: issues, concerns and future prospects;Dalakas;Nat Rev Rheumatol,2010

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contribution of Flexig mobile application to assess adherence of patients treated with immunoglobulins in chronic diseases;Journal of Allergy and Clinical Immunology: Global;2024-02

2. Subcutaneous immunoglobulin for patients with idiopathic inflammatory myopathies: a real-world, single-centre experience;Rheumatology;2023-10-05

3. The EHA Research Roadmap: Transfusion Medicine;HemaSphere;2022-01-25

4. Immune Neuropathies;Acquired Neuromuscular Disorders;2022

5. Treatment and Management of Autoimmune Neuropathies;Neuromuscular Disorders;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3